Back to Search Start Over

Overcoming Barriers to Tobacco Cessation and Lung Cancer Screening among Racial and Ethnic Minority Groups and Underserved Patients in Academic Centers and Community Network Sites: The City of Hope Experience.

Authors :
Presant, Cary A.
Ashing, Kimlin
Raz, Dan
Yeung, Sophia
Gascon, Brenda
Stewart, Alexis
Macalintal, Jonjon
Sandoval, Argelia
Ehrunmwunsee, Loretta
Phillips, Tanyanika
Salgia, Ravi
Merla, Amartej
Subbiah, Shanmuga
El-Hajjouie, Michelle
Staley, Jeffrey
Graves, Heather
Pathak, Ranjan
Dingal, Shaira
Sampath, Sagus
Laksana, Beverly
Source :
Journal of Clinical Medicine. Feb2023, Vol. 12 Issue 4, p1275. 9p.
Publication Year :
2023

Abstract

Background: Tobacco control is important for cancer patient health, but delivering effective low-dose CT (LDCT) screening and tobacco cessation is more difficult in underserved and patients from racial and ethnic minority groups. At City of Hope (COH), we have developed strategies to overcome barriers to the delivery of LDCT and tobacco cessation. Methods: We performed a needs assessment. New tobacco control program services were implemented focusing on patients from racial and ethnic minority groups. Innovations included Whole Person Care with motivational counseling, placing clinician and nurse champions at points of care, training module and leadership newsletters, and a patient-centric personalized medicine Personalized Pathways to Success (PPS) program. Results: Emphasis on patients from racial and ethnic minority groups was implemented by training cessation personnel and lung cancer control champions. LDCT increased. Tobacco use assessment increased and abstinence was 27.2%. The PPS pilot program achieved 47% engagement in cessation, with self-reported abstinence at 3 months of 38%, with both results slightly higher in patients from racial and ethnic minority groups than in Caucasian patients. Conclusions: Tobacco cessation barrier-focused innovations can result in increased lung cancer screening and tobacco cessation reach and effectiveness, especially among patients from racial and ethnic minority groups. The PPS program is promising as a personalized medicine patient-centric approach to cessation and lung cancer screening. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
20770383
Volume :
12
Issue :
4
Database :
Academic Search Index
Journal :
Journal of Clinical Medicine
Publication Type :
Academic Journal
Accession number :
162137338
Full Text :
https://doi.org/10.3390/jcm12041275